GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

ABVC Biopharma ABVC · USD

N/A · US listing · 🇺🇸 United States

Compare

0.97

-2.88%

Close of 5 Nov 2026, in USD

Earnings against forecasts

Earnings per share by fiscal quarter

Q2 2026Q3 2025Q2 2025Q4 2024Q3 2024Q2 2024Q4 2023Q3 2023
Forecast-0.40-0.40-0.60-1.50-2.00-1.25-0.50-0.40
Reported-0.03-0.05-0.130.02-0.02-0.09-0.35-0.82
Difference+92.5%+87.5%+78.3%+101.1%+99.0%+92.8%+30.0%-105.0%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

4 / 10

Revenue growth 72.8% a year over 10 years. Return on equity -71.2%.

Model fair value

0.91

From earnings —, from revenue 0.91.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.